𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma

✍ Scribed by Ronald S. Walters; Debra Frye; Aman U. Buzdar; Frankie A. Holmes; Gabriel N. Hortobagyi

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
480 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of 5-fluorouracil, doxo
A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma
✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 1 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

A randomized Phase II trial of two dosag
A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma
✍ James N. Ingle; Patricia A. Johnson; Vera J. Suman; James B. Gerstner; James A. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

letrozole dosage levels, 0.5 mg and 2.5 mg per day, was performed. Eligibility requirements included failure on two prior hormonal therapies and measurable